Literature DB >> 32587786

Erratum to Prevalence and clinical significance of pathogenic germline BRCA1/2 mutations in Chinese non-small cell lung cancer patients.

Xingsheng Hu1, Dongyong Yang2, Yalun Li3, Li Li4, Yan Wang5, Peng Chen6, Song Xu7, Xingxiang Pu8, Wei Zhu9, Pengbo Deng10, Junyi Ye11, Hanhan Zhang11, Analyn Lizaso11, Hao Liu11, Xinru Mao11, Hai Huang11, Qian Chu12, Chengping Hu10.   

Abstract

Entities:  

Year:  2020        PMID: 32587786      PMCID: PMC7309464          DOI: 10.20892/j.issn.2095-3941.2020.0029

Source DB:  PubMed          Journal:  Cancer Biol Med        ISSN: 2095-3941            Impact factor:   4.248


× No keyword cloud information.
In the published article[1], the affiliation for the first author, Xingsheng Hu, is “Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences”, we would like to update it to “Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China”. We apologize for the errors and for any confusion it may have caused.
  1 in total

1.  Prevalence and clinical significance of pathogenic germline BRCA1/2 mutations in Chinese non-small cell lung cancer patients.

Authors:  Xingsheng Hu; Dongyong Yang; Yalun Li; Li Li; Yan Wang; Peng Chen; Song Xu; Xingxiang Pu; Wei Zhu; Pengbo Deng; Junyi Ye; Hanhan Zhang; Analyn Lizaso; Hao Liu; Xinru Mao; Hai Huang; Qian Chu; Chengping Hu
Journal:  Cancer Biol Med       Date:  2019-08       Impact factor: 4.248

  1 in total
  1 in total

1.  Apolipoprotein C1 (APOC1): A Novel Diagnostic and Prognostic Biomarker for Cervical Cancer.

Authors:  Xiu Shi; Juan Wang; Shouqian Dai; Lingyan Qin; Jinhua Zhou; Youguo Chen
Journal:  Onco Targets Ther       Date:  2020-12-15       Impact factor: 4.147

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.